Anuj Mahindra, MD

Anuj Mahindra is a hematologist and medical oncologist with a special interest in blood cancers and bone marrow transplantation. In addition to his clinical practice, he is actively involved in the design and conduct of clinical trials in blood cancers. He has been a principal investigator on multiple early to late phase clinical trials as well as the author of several review papers and book chapters.

He graduated from University of Delhi / Maulana Azad Medical College and specializes in hematology and medical oncology. He completed his residencies at Good Samaritan Hospital-Maryland in internal medicine, and his Fellowships from Cleveland Clinic Foundation in hematology & oncology.

Dr. Mahindra was previously on the faculty at Harvard Medical School and a member of the Multiple Myeloma Program at Dana-Farber/Harvard Cancer Center. Dr. Mahindra believes in working as part of a collaborative multidisciplinary team that includes other physicians, nurses, pharmacists and specialists to provide excellent and compassionate patient care.

Representative Publications:
Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autotransplants for Lymphomas and Plasma Cell Myeloma.
The Use of Novel Agents in the Treatment of Relapsed and Refractory Multiple Myeloma.
Hematopoietic Cell Transplantation for Primary Plasma Cell Leukemia: Results from the Center for International Blood and Marrow Transplant Research.
Autologous Hematopoietic Cell Transplantation for Multiple Myeloma Patients With Renal Insufficiency: A Center for International Blood and Marrow Transplant Research Analysis.